RhoA/rho kinase signaling reduces connexin43 expression in high glucose-treated glomerular mesangial cells with zonula occludens-1 involvement

Experimental Cell Research

Volumn 327, Issue 2, 2014, Pages 276-286

  Xie, Xi ^a,b   Chen, Cheng ^a   Huang, Kaipeng ^a   Wang, Shaogui ^a   Hao, Jie ^a   Huang, Junying ^a   Huang, Heqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b HAINAN UNIVERSITY   (China)

Author keywords

Connexin43; F actin; RhoA Rho kinase; Zonula occludens 1

Indexed keywords

CONNEXIN 43; F ACTIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN ZO1; RHO KINASE; SYNAPTOTAGMIN I; CONNEXIN 43 PROTEIN, RAT; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SWEETENING AGENT; TJP1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CELL COMMUNICATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; GAP JUNCTION; GENE EXPRESSION; GENE TRANSLOCATION; GLOMERULAR MESANGIAL CELL; MALE; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; APOPTOSIS; CELL CULTURE; CELL PROLIFERATION; CONNEXIN43; CYTOLOGY; DRUG EFFECT; F-ACTIN; IMMUNOPRECIPITATION; METABOLISM; RHOA/RHO KINASE; SPRAGUE DAWLEY RAT; WESTERN BLOTTING; ZONULA OCCLUDENS-1;

CONNEXIN43; F-ACTIN; RHOA/RHO KINASE; ZONULA OCCLUDENS-1;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CONNEXIN 43; GLUCOSE; IMMUNOPRECIPITATION; MALE; MESANGIAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SWEETENING AGENTS; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84907684189     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.07.019     Document Type: Article

References (44)

1. Ritz E., Rychlik I., Locatelli F., Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am. J. Kidney Dis. 1999, 34:795-808.
2. Tuttle K.R. Linking metabolism and immunology: Diabetic nephropathy is an inflammatory disease. J. Am. Soc. Nephrol. 2005, 16:1537-1538.
3. Navarro-Gonzalez J.F., Mora-Fernandez C., de Fuentes M.M., Garcia-Perez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat. Rev. Nephrol. 2011, 7:327-340.
4. Xie X., Peng J., Chang X., Huang K., Huang J., Wang S., Shen X., Liu P., Huang H. Activation of RhoA/ROCK regulates NF-kappaB signaling pathway in experimental diabetic nephropathy. Mol. Cell. Endocrinol. 2013, 369:86-97.
5. Ridley A.J. Rho family proteins: coordinating cell responses. Trends Cell Biol. 2001, 11:471-477.
6. Loirand G., Guerin P., Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ. Res. 2006, 98:322-334.
7. Massey A.R., Miao L., Smith B.N., Liu J., Kusaka I., Zhang J.H., Tang J. Increased RhoA translocation in renal cortex of diabetic rats. Life Sci. 2003, 72:2943-2952.
8. Danesh F.R., Sadeghi M.M., Amro N., Philips C., Zeng L., Lin S., Sahai A., Kanwar Y.S. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: implications for diabetic nephropathy. Proc. Natl. Acad. Sci. USA 2002, 99:8301-8305.
9. Xie X., Peng J., Chang X., Huang K., Huang J., Wang S., Shen X., Liu P., Huang H. Activation of RhoA/ROCK regulates NF-kappaB signaling pathway in experimental diabetic nephropathy. Mol. Cell. Endocrinol. 2013.
10. Herve J.C., Bourmeyster N., Sarrouilhe D., Duffy H.S. Gap junctional complexes: from partners to functions. Progress Biophys. Mol. Biol. 2007, 94:29-65.
11. Evans W.H., Martin P.E. Gap junctions: structure and function (Review). Mol. Membr. Biol. 2002, 19:121-136.
12. Yao J., Zhu Y., Morioka T., Oite T., Kitamura M. Pathophysiological roles of gap junction in glomerular mesangial cells. J. Membr. Biol. 2007, 217:123-130.
13. Zhang X., Chen X., Wu D., Liu W., Wang J., Feng Z., Cai G., Fu B., Hong Q., Du J. Downregulation of connexin 43 expression by high glucose induces senescence in glomerular mesangial cells. J. Am. Soc. Nephrol. 2006, 17:1532-1542.
14. Sawai K., Mukoyama M., Mori K., Yokoi H., Koshikawa M., Yoshioka T., Takeda R., Sugawara A., Kuwahara T., Saleem M.A., Ogawa O., Nakao K. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy. Nephrol. Dial Transplant. 2006, 21:2472-2477.
15. Takenaka T., Inoue T., Okada H., Ohno Y., Miyazaki T., Chaston D.J., Hill C.E., Suzuki H. Altered gap junctional communication and renal haemodynamics in Zucker fatty rat model of type 2 diabetes. Diabetologia 2011, 54:2192-2201.
16. Liu L., Hu X., Cai G.Y., Lv Y., Zhuo L., Gao J.J., Cui S.Y., Feng Z., Fu B., Chen X.M. High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling. Nephrol. Dial Transplant. 2012, 27:90-100.
17. Xie X., Lan T., Chang X., Huang K., Huang J., Wang S., Chen C., Shen X., Liu P., Huang H. Connexin43 mediates NF-kappaB signaling activation induced by high glucose in GMCs: involvement of c-Src. Cell Commun. Signal.: CCS 2013, 11:38.
18. Anderson S.C., Stone C., Tkach L., SundarRaj N. Rho and Rho-kinase (ROCK) signaling in adherens and gap junction assembly in corneal epithelium. Investig. Ophthalmol. Vis. Sci. 2002, 43:978-986.
19. Ponsaerts R., D'Hondt C., Hertens F., Parys J.B., Leybaert L., Vereecke J., Himpens B., Bultynck G. RhoA GTPase switch controls Cx43-hemichannel activity through the contractile system. PloS one 2012, 7:e42074.
20. Suh H.N., Kim M.O., Han H.J. Laminin-111 stimulates proliferation of mouse embryonic stem cells through a reduction of gap junctional intercellular communication via RhoA-mediated Cx43 phosphorylation and dissociation of Cx43/ZO-1/drebrin complex. Stem Cells Dev. 2012, 21:2058-2070.
21. Geoffroy K., Wiernsperger N., Lagarde M., El Bawab S. Bimodal effect of advanced glycation end products on mesangial cell proliferation is mediated by neutral ceramidase regulation and endogenous sphingolipids. J. Biol. Chem. 2004, 279:34343-34352.
22. Jiang Q., Liu P.Q., Wu X.Q., Liu W.H., Shen X.Y., Lan T.A., Xu S.W., Peng J., Xie X., Huang H.Q. Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: Involvement of NF-kappa B signaling pathway. Mol. Cell Endocrinol. 2011, 331:34-40.
23. Liu W.H., Zhang X.Y., Liu P.Q., Shen X.Y., Lan T.A., Li W.Y., Jiang Q., Xie X., Huang H.Q. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. Eur. J. Pharmacol. 2010, 638:150-155.
24. Gangoso E., Herrero-Gonzalez S., Giaume C., Naus C., Medina J.M., Tabernero A. Connexin43 inhibits the oncogenic activity of c-Src in C6 glioma cells. FEBS J. 2011, 278:456.
25. Xie X., Peng J., Huang K., Huang J., Shen X., Liu P., Huang H. Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-kappaB signaling pathway in rat glomerular mesangial cells. Mol. Cell Endocrinol. 2012, 362:183-193.
26. Lan T., Shen X., Liu P., Liu W., Xu S., Xie X., Jiang Q., Li W., Huang H. Berberine ameliorates renal injury in diabetic C57BL/6 mice: involvement of suppression of SphK-S1P signaling pathway. Arch. Biochem. Biophys. 2010, 502:112-120.
27. Noma K., Oyama N., Liao J.K. Physiological role of ROCKs in the cardiovascular system. Am. J. Physiol.: Cell Physiol. 2006, 290:C661-668.
28. Derangeon M., Bourmeyster N., Plaisance I., Pinet-Charvet C., Chen Q., Duthe F., Popoff M.R., Sarrouilhe D., Herve J.C. RhoA GTPase and F-actin dynamically regulate the permeability of Cx43-made channels in rat cardiac myocytes. J. Biol. Chem. 2008, 283:30754-30765.
29. Singh D., Solan J.L., Taffet S.M., Javier R., Lampe P.D. Connexin 43 interacts with zona occludens-1 and -2 proteins in a cell cycle stage-specific manner. J. Biol. Chem. 2005, 280:30416-30421.
30. Giepmans B.N., Moolenaar W.H. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr. Biol.: CB 1998, 8:931-934.
31. Zhu C., Barker R.J., Hunter A.W., Zhang Y., Jourdan J., Gourdie R.G. Quantitative analysis of ZO-1 colocalization with Cx43 gap junction plaques in cultures of rat neonatal cardiomyocytes,. Microsc. Microanal.: Off. J. Microsc. Soc. Am. 2005, 11:244-248.
32. Giepmans B.N. Gap junctions and connexin-interacting proteins. Cardiovasc. Res. 2004, 62:233-245.
33. Hunter A.W., Barker R.J., Zhu C., Gourdie R.G. Zonula occludens-1 alters connexin43 gap junction size and organization by influencing channel accretion. Mol. Biol. Cell 2005, 16:5686-5698.
34. Tence M., Ezan P., Amigou E., Giaume C. Increased interaction of connexin43 with zonula occludens-1 during inhibition of gap junctions by G protein-coupled receptor agonists. Cell Signal 2012, 24:86-98.
35. Barker R.J., Price R.L., Gourdie R.G. Increased association of ZO-1 with connexin43 during remodeling of cardiac gap junctions. Circ. Res. 2002, 90:317-324.
36. Segretain D., Fiorini C., Decrouy X., Defamie N., Prat J.R., Pointis G. A proposed role for ZO-1 in targeting connexin 43 gap junctions to the endocytic pathway. Biochimie 2004, 86:241-244.
37. Musil L.S., Goodenough D.A. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J. Cell Biol. 1991, 115:1357-1374.
38. Laird D.W., Puranam K.L., Revel J.P. Turnover and phosphorylation dynamics of connexin43 gap junction protein in cultured cardiac myocytes. Biochem. J. 1991, 273(Pt. 1):67-72.
39. Laird D.W., Castillo M., Kasprzak L. Gap junction turnover, intracellular trafficking, and phosphorylation of connexin43 in brefeldin A-treated rat mammary tumor cells. J. Cell Biol. 1995, 131:1193-1203.
40. Stevenson B.R., Siliciano J.D., Mooseker M.S., Goodenough D.A. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J. Cell Biol. 1986, 103:755-766.
41. Denker B.M., Nigam S.K. Molecular structure and assembly of the tight junction. Am. J. Physiol. 1998, 274:F1-9.
42. Toyofuku T., Yabuki M., Otsu K., Kuzuya T., Hori M., Tada M. Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. J. Biol. Chem. 1998, 273:12725-12731.
43. Rouach N., Pebay A., Meme W., Cordier J., Ezan P., Etienne E., Giaume C., Tence M. S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK. Eur. J. Neurosci. 2006, 23:1453-1464.
44. Tadvalkar G., Pinto da Silva P. In vitro, rapid assembly of gap junctions is induced by cytoskeleton disruptors. J. Cell Biol. 1983, 96:1279-1287.